For Brooks Laboratories, the day proved to be not as good as its shares sloped downwards and touched the days lowest of Rs 57.75 and closed down at Rs 60.20 on BSE. Today, the strong economy of India made it possible for the market to trade 7.5 crore equity shares.

Although the day was not that profitable for Brooks, as a share did opened at Rs 110. Following the downward trend of the Brooks share, the Chairman of the company, Atul Ranchal assured that the company will do better in the coming future. The company is envisaging to book sales of Rs 125 crore by reaching its profits to Rs 20 crore, in 2013.

The Company is also looking forward towards establishing a manufacturing unit in Gujarat. In this unit, various pharmaceuticals formulations will be manufactured. The establishment will cost about Rs 51.8 crore. However, prior to beginning the manufacture work, the Company will need Rs 5 crore as working capital.

It has been unveiled that the Company was successful in raising Rs. 630mn through its IPO which was opened in 16th and 18th of August. Half of the money raised by the IPO will be utilized as the working Capital for the proposed unit to be established in Gujarat.